• CMS gives a big boost to broad genomic tests by widening coverage for sequencing

    One year ago - By MedCity News

    Foundation Medicine and ThermoFisher Scientific are big beneficiaries of CMS widening its coverage and making a national coverage decision for next-generation sequencing of metastatic, Stage 3 or 4 and other cancers.
    Read more ...